Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa

Background. In 1995, the hepatitis B vaccine in South Africa was incorporated into the childhood expanded programme of immunization. We report on immunity gaps of laboratory-based hepatitis B virus (HBV) among patients in public facilities in Gauteng Province from 1st January 2014 to 31st December 2...

Full description

Saved in:
Bibliographic Details
Main Authors: Nonhlanhla Mbenenge, Kathleen Subramoney, Clement Gascua Adu-Gyamfi, Florette K. Treurnicht
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Advances in Virology
Online Access:http://dx.doi.org/10.1155/2023/6374874
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850186221529071616
author Nonhlanhla Mbenenge
Kathleen Subramoney
Clement Gascua Adu-Gyamfi
Florette K. Treurnicht
author_facet Nonhlanhla Mbenenge
Kathleen Subramoney
Clement Gascua Adu-Gyamfi
Florette K. Treurnicht
author_sort Nonhlanhla Mbenenge
collection DOAJ
description Background. In 1995, the hepatitis B vaccine in South Africa was incorporated into the childhood expanded programme of immunization. We report on immunity gaps of laboratory-based hepatitis B virus (HBV) among patients in public facilities in Gauteng Province from 1st January 2014 to 31st December 2019. Methodology. We analyzed HBV serological data extracted from the National Health Laboratory Services Central Data Warehouse (NHLS CDW). A descriptive analysis was performed for hepatitis B surface antigen (HBsAg), antibodies to HBV core (anti-HBc) total, anti-HBc IgM, and antibodies to HBV surface antigen (anti-HBs) according to annual distribution, age groups, and sex. Results. The HBsAg positivity rate was 7.0% (75,596/1,095,561; p=0.001): 7.4% (96,532/944,077) in the 25 years and over age group and 4.0% (358/9,268 and 325/10,864) in the under 5 and 13–24 year age groups. The positivity rates of the other HBV serological markers were as follows: anti-HBc total was 37.0% (34,377/93,711; p < 0.001), anti-HBc IgM was 2.4% (5,661/239,237; p=0.05), and anti-HBs was 37.0% (76,302/206,138; p≤0.001). Naturally acquired HBV immunity was detected in 25.7% (11,188/43,536) of patients in the 25 years and over age group, and 9.7% and 8.2% (113/1,158 and 541/6,522) among those under 5 years and 13–24 year age group, respectively (p < 0.001). Vaccine-induced immunity was 56.6% (656/1,158) in children under 5 years and 10.2% (4,425/43,536) among those 25 years and above (p < 0.001). Fifty-six percent (29,404/52,581) of patients were HBV seronegative; predominantly among patients in the 13–24 year age group (60.6%; (3,952/6,522)) and 25 years and over (56.3% (24,524/43,536)) (p=<0.001). Conclusion. The HBV infection seroprevalence remains high in South Africa, with Gauteng province having high intermediate endemicity. However, the HBV immunity gap has shifted from younger children to older children and adults.
format Article
id doaj-art-3aecbc4810014e13b60fb233e95838eb
institution OA Journals
issn 1687-8647
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Advances in Virology
spelling doaj-art-3aecbc4810014e13b60fb233e95838eb2025-08-20T02:16:23ZengWileyAdvances in Virology1687-86472023-01-01202310.1155/2023/6374874Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South AfricaNonhlanhla Mbenenge0Kathleen Subramoney1Clement Gascua Adu-Gyamfi2Florette K. Treurnicht3School of PathologySchool of PathologyBrain Function Research Group (BFRG)School of PathologyBackground. In 1995, the hepatitis B vaccine in South Africa was incorporated into the childhood expanded programme of immunization. We report on immunity gaps of laboratory-based hepatitis B virus (HBV) among patients in public facilities in Gauteng Province from 1st January 2014 to 31st December 2019. Methodology. We analyzed HBV serological data extracted from the National Health Laboratory Services Central Data Warehouse (NHLS CDW). A descriptive analysis was performed for hepatitis B surface antigen (HBsAg), antibodies to HBV core (anti-HBc) total, anti-HBc IgM, and antibodies to HBV surface antigen (anti-HBs) according to annual distribution, age groups, and sex. Results. The HBsAg positivity rate was 7.0% (75,596/1,095,561; p=0.001): 7.4% (96,532/944,077) in the 25 years and over age group and 4.0% (358/9,268 and 325/10,864) in the under 5 and 13–24 year age groups. The positivity rates of the other HBV serological markers were as follows: anti-HBc total was 37.0% (34,377/93,711; p < 0.001), anti-HBc IgM was 2.4% (5,661/239,237; p=0.05), and anti-HBs was 37.0% (76,302/206,138; p≤0.001). Naturally acquired HBV immunity was detected in 25.7% (11,188/43,536) of patients in the 25 years and over age group, and 9.7% and 8.2% (113/1,158 and 541/6,522) among those under 5 years and 13–24 year age group, respectively (p < 0.001). Vaccine-induced immunity was 56.6% (656/1,158) in children under 5 years and 10.2% (4,425/43,536) among those 25 years and above (p < 0.001). Fifty-six percent (29,404/52,581) of patients were HBV seronegative; predominantly among patients in the 13–24 year age group (60.6%; (3,952/6,522)) and 25 years and over (56.3% (24,524/43,536)) (p=<0.001). Conclusion. The HBV infection seroprevalence remains high in South Africa, with Gauteng province having high intermediate endemicity. However, the HBV immunity gap has shifted from younger children to older children and adults.http://dx.doi.org/10.1155/2023/6374874
spellingShingle Nonhlanhla Mbenenge
Kathleen Subramoney
Clement Gascua Adu-Gyamfi
Florette K. Treurnicht
Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
Advances in Virology
title Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_full Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_fullStr Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_full_unstemmed Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_short Hepatitis B Virus Immunity Gap: A Six-Year Laboratory Data Review of Hepatitis B Serological Profiles in Gauteng Province, South Africa
title_sort hepatitis b virus immunity gap a six year laboratory data review of hepatitis b serological profiles in gauteng province south africa
url http://dx.doi.org/10.1155/2023/6374874
work_keys_str_mv AT nonhlanhlambenenge hepatitisbvirusimmunitygapasixyearlaboratorydatareviewofhepatitisbserologicalprofilesingautengprovincesouthafrica
AT kathleensubramoney hepatitisbvirusimmunitygapasixyearlaboratorydatareviewofhepatitisbserologicalprofilesingautengprovincesouthafrica
AT clementgascuaadugyamfi hepatitisbvirusimmunitygapasixyearlaboratorydatareviewofhepatitisbserologicalprofilesingautengprovincesouthafrica
AT florettektreurnicht hepatitisbvirusimmunitygapasixyearlaboratorydatareviewofhepatitisbserologicalprofilesingautengprovincesouthafrica